Nicolas J Llosa (Nicolas Llosa)

Years Active: 2022-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Jiawan Wang, Ana Calizo, Lindy Zhang, James C Pino, Yang Lyu, Kai Pollard, Xiaochun Zhang, Alex T Larsson, Eric Conniff, Nicolas J Llosa, David K Wood, David A Largaespada, Susan E Moody, Sara J C Gosline, Angela C Hirbe, Christine A Pratilas
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors. Science advances 9 (47) (2023)
John A Ligon, Woonyoung Choi, Gady Cojocaru, Wei Fu, Emily Han-Chung Hsiue, Teniola F Oke, Nicholas Siegel, Megan H Fong, Brian Ladle, Christine A Pratilas, Carol D Morris, Adam Levin, Daniel S Rhee, Christian F Meyer, Ada J Tam, Richard Blosser, Elizabeth D Thompson, Aditya Suru, David McConkey, Franck Housseau, Robert Anders, Drew M Pardoll, Nicolas J Llosa
Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes. Journal for immunotherapy of cancer 9 (5) (2022)
Laurene S Cheung, Lingling Chen, Teniola F Oke, Thomas B Schaffer, Karim Boudadi, Jillian T Ngo, John McMahon Gross, Holly Kemberling, Luis A Diaz, Evan J Lipson, John-William Sidhom, Janis Taube, Robert Anders, Drew M Pardoll, Dung T Le, Christian F Meyer, Nicolas J Llosa
Anti-PD-1 elicits regression of undifferentiated pleomorphic sarcomas with UV-mutation signatures. Journal for immunotherapy of cancer 9 (6) (2022)

Nicolas J Llosa.css-eqlu8i{font-size:small;padding-left:4px;} (Nicolas Llosa)